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Yersinia enterocolitica has three type three secretion systems, the flagellar, the plasmid Ysc type III secretion
system (T3SS), and the chromosomal Ysa T3SS. The Ysc T3SS, through the proteins it secretes (Yops),
prevents phagocytosis of Y. enterocolitica and is required for disease processes in the mouse host. Recent data
demonstrate a role for the Ysa T3SS during initial colonization of the mouse via secretion of Ysps (Yersinia
secreted proteins). This work characterizes the discovery of a newly identified Ysa type III secreted protein,
YspM. Expression of yspM is regulated by temperature, NaCl concentration, and other known regulators of the
ysa system. In addition, YspM is translocated into host cells via the Ysa T3SS. YspM is homologous to proteins
classified as GDSL bacterial lipases, which possess a catalytic triad of amino acids (Ser, Asp, and His) located
in three of five blocks of amino acid identity. Sequence analysis of the JB580v strain of Y. enterocolitica shows
that, due to a premature stop codon, it no longer encodes the fifth block of amino acid identity containing the
predicted catalytic histidine. However, seven other biotype 1B strains sequenced did possess the domain. A
functional difference between the forms was revealed when YspM was expressed in Saccharomyces cerevisiae.
Yeast growth was uninhibited when YspM from JB580v was expressed but greatly inhibited when YspM from
Y295 (YspMY295) was expressed. Site-directed mutagenesis of the histidine of YspMY295 ablated the toxic
effects. These results indicate that YspM is secreted by the Ysa T3SS and that, possibly due to lipase activity,
it targets eukaryotic cellular component(s).
Yersinia enterocolitica is a gram-negative, enteric pathogen
that infects humans through ingestion of contaminated food or
water. Infected individuals can develop several disease mani-
festations including self-limiting enteritis, diarrhea, lymphade-
nitis, and, in severe cases, septicemia leading to death (6, 22).
Orally infected mice develop a similar disease and serve as a
useful tool to study Y. enterocolitica pathogenesis (8, 16, 17).
The mouse model has been used to demonstrate that upon
infection, Y. enterocolitica transverses the stomach and colo-
nizes the small intestine, where the bacteria invade and repli-
cate within Peyer’s patches (2, 8, 28). The ability to survive
within Peyer’s patches is due, in part, to the presence of a
plasmid-encoded Ysc-Yop type III secretion system (T3SS)
(39). Several of the secreted effector Yops prevent phagocyto-
sis of Y. enterocolitica by macrophages and polymorphonuclear
cells due to their immune modulatory functions (10). This is a
process of critical importance, demonstrated by the fact that Y.
enterocolitica bacteria lacking specific Yops do not colonize the
Peyer’s patches, mesenteric lymph nodes, or spleens to levels
seen with wild-type bacteria (39).
Biotype 1B strains of Y. enterocolitica, which is the most
pathogenic of the species, possess a second T3SS, the chromo-
somally encoded Ysa (Yersinia secretion apparatus) T3SS (12,
15). The Ysa T3SS is responsible for secreting at least 15 Ysps,
or Yersinia secreted proteins, when cultures are grown at 26°C
in the presence of 290 mM NaCl (23, 47). While the exact role
the Ysa T3SS plays in pathogenicity has yet to be determined,
there is a decrease in virulence when a commonly used biotype
1B strain, JB580v, lacking a functional Ysa T3SS is used to
infect mice. These Ysa T3SS mutant strains have a 10-fold
attenuation, based on 50% lethal dose analysis, following oral
inoculation and are deficient in their ability to colonize the
terminal ileum of the mouse during the first 24 h of oral
infection (15, 23). Several Ysps have been shown to have a role
in the early colonization events of the gastrointestinal tract, as
demonstrated by competitive index analysis following oral in-
oculation (23). Interestingly, strains of bacteria lacking some
Ysps have a greater colonization defect than a ysa apparatus
mutant alone. Two Ysps that had a defect in colonization of
the mouse, YspP and YspK, have been further characterized to
have enzymatic properties. YspK has demonstrated protein
kinase activity, and YspP has demonstrated phosphatase activ-
ity (23).
Expression of the Ysa T3SS and secretion of its cognate
Ysps are regulated by both environmental (high NaCl and
lower temperatures) and genetic factors. Genetic factors in-
volved in regulation of the ysa T3SS include the putative phos-
phorelay systems encoded by ysrRS and rcsC-yojN-rcsB as well
as the araC-like regulator YsaE and the chaperone SycB (42,
43). Genes encoding the ysa apparatus, the chaperone sycB,
and four genes (yspBCDA) that encode proteins with homol-
ogy to proteins involved in host cell pore formation are located
in a single genetic locus, and expression is controlled by two
promoters. The genetic organization of the locus reveals that
the ysaE promoter drives transcription of a long transcript that
encodes the structural genes that make up the ysa secretion
apparatus, sycB, and yspBCDA. Upon expression, YsaE and
SycB act in concert to further activate transcription of the
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sycB-yspBCDA operon (43). YsrRS and RcsC-YojN-RcsB are
believed to be responsible for sensing changes in the environ-
ment and then activating expression of the ysa operon. In
support of this model, it has been shown that not only YsaE
and SycB but also YsrRS and RcsB are required for secretion
of Ysps by the Ysa T3SS (42, 43). Interestingly, with the ex-
ception of yspBCDA, the other Ysps are encoded elsewhere
throughout the chromosome, and little is known about the
regulation of their expression.
As the ysp genes are not located together on the Y. entero-
colitica chromosome, it remains possible that there are addi-
tional, unidentified proteins secreted by the Ysa T3SS. Com-
parative phylogenomic analysis of Y. enterocolitica by Howard
et al. identified an open reading frame (ORF), YE3614, with
homology to a type III secreted protein of Salmonella (18).
Work in our laboratory also identified YE3614 as a potential
type III secreted protein (unpublished data). In this work, we
examined the ability of YE3614 to be secreted and translo-
cated by the Ysa T3SS. We also investigated the regulation of
expression of YE3614 compared to other genes of the ysa
regulon. Finally, we examined the effects of expression of
YE3614 in eukaryotic cells using the Saccharomyces cerevisiae
model system.
MATERIALS AND METHODS
Strains and growth conditions. The bacterial strains, yeast strains, and plas-
mids used in this study are presented in Table 1 and further described below.
Unless indicated, bacterial cultures were grown overnight in Luria broth (LB)
(170 mM NaCl) at 26°C for Y. enterocolitica or 37°C for Escherichia coli. For
promotion of protein secretion via the Ysa T3SS, bacteria were grown overnight
TABLE 1. Strains and plasmids
Strain or plasmid Description Reference or source
Bacteria strains
JB580v Y. enterocolitica 8081v yenR(r m); wild type 19
JB580c JB580v cured of plasmid pYVe8081; lacks Ysc/Yop T3SS 43
Y295 Y. enterocolitica, biotype 1B, O:8 26
657-83 Y. enterocolitica, biotype 1B, O:20 4,26
658-83 Y. enterocolitica, biotype 1B, O:21 4,26
655-83 Y. enterocolitica, biotype 1B, O:18 4,26
634-83 Y. enterocolitica, biotype 1B, O:4,32 4,26
9286-78 Y. enterocolitica, biotype 1B, O:20 3,26
9287-78 Y. enterocolitica, biotype 1B, O:20 3
2440-87 Y. enterocolitica, biotype 1B, O:8 4,26
YVM1374 JB580v yscC This study
YVM1178 JB580v ysaC This study
YVM932 JB580v ysaE 43
YVM981 JB580v sycB 43
YVM1006 JB580v ysrR 43
YVM969 JB580v ysrS 43
YVM1236 JB580v rcsB This study
E. coli S17-1 pir Tpr Strr recA thi pro hsdR hsdM RP4::2-Tc::Mu::Km Tn7 pir lysogen 25
Yeast strains
SCW01 S. cerevisiae MATa leu20 met150 ura30 Gift of Vogel
lab
SCW06 SCW01 containing pDEST52 This study
SCW07 SCW01 containing pSW13 This study
SCW08 SCW01 containing pSW16 This study
SCW11 SCW01 containing pSW46 This study
Plasmids
pSIF003-R1 Used for PCR amplification of cyaA 41
pENTR-SD-TOPO Kanr cloning vector Invitrogen
pDEST52 GAL1 promoter, C-terminal V5 epitope tag, 2m ori URA3 Invitrogen
pKW44 pWKS130 backbone; for construction of C-terminal cyaA translation fusions This study
pSW11 yspM8081v cloned into pENTR-SD-TOPO This study
pSW12 yspMY295 cloned into pENTR-SD-TOPO This study
pSW13 GAL1 promoter driving expression of YspM8081v-V5 fusion protein This study
pSW16 GAL1 promoter driving expression of YspMY295-V5 fusion protein This study
pSW29 yspMY295(H304N) cloned into pENTR-SD-TOPO This study
pSW41 yopE promoter and yspM8081v codons 1 to 150 cloned into pKW44 This study
pSW42 500-bp yspM8081v promoter region cloned into pKW44 This study
pSW43 500-bp yspM8081v promoter region and yspM8081v codons 1 to 150 cloned into pKW44 This study
pSW45 500-bp yspMY295 promoter region and yspMY295 codons 1 to 150 cloned into pKW44 This study
pSW46 GAL1 promoter driving expression of YspMY295(H304N)-V5 fusion protein This study
pSW47 500-bp flanking regions of ysaC ORF in pSR47S; for construction of yscC strain This study
pKW43 500-bp flanking regions of ysaC ORF in pSR47S; for construction of ysaC strain This study
pKW53 500-bp flanking regions of rcsB ORF in pSR47S; for construction of rcsB strain This study
pWKS130 Kanr; low-copy-number cloning vector 44
pSR47S Kanr mobRP4 oriR6K; cloning vector 24
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in LB lacking NaCl at 26°C and subcultured into LB plus 290 mM NaCl. For
examination of protein secretion via the Ysc T3SS, bacteria were grown over-
night in LB at 26°C and subcultured into LB containing 20 mM Na2C2O4 and 20
mM MgCl2 and grown at 37°C. Antibiotics were used as needed at the following
concentrations: carbenicillin, 50 g/ml; kanamycin, 100 g/ml; and nalidixic acid,
20 g/ml.
S. cerevisiae was grown in YPD (yeast extract, peptone, and dextrose) medium
at 30°C unless otherwise indicated. For protein induction studies, S. cerevisiae
was grown at 30°C in synthetic complete medium [500 ml of medium contains
2.5g (NH4)2SO4, 0.85 g of yeast nitrogen base, and 1 g of dropout mix minus
uracil for plasmid maintenance (US Biological)] containing either 2% glucose or
2% galactose.
Plasmid construction. The plasmids used to detect secretion of YE3614 under
various conditions were generated as follows. The primers used in this study are
listed in Table 2. All PCR fragments generated in this study were sequenced to
confirm that no undesired mutations were incorporated into the DNA and that
the desired mutations were incorporated. The ORF of the cyaA gene of Borde-
tella pertussis was amplified using primers KW104 and KW105 from plasmid
pSIF003-R1 (41) (a gift from the laboratory of J. Vogel, Washington University).
The fragment was digested with XbaI and BamHI and cloned into the same sites
of pWKS130, resulting in plasmid pKW44. Primers P1 and P2 were used to
amplify an approximately 1,000-bp product containing 500 bp upstream of the
start codon and 500 bp of the ORF of YE3614 from JB580v to include the first
150 amino acids of YE3614. This fragment was digested with NotI and XbaI and
cloned into the same sites of pKW44, resulting in pSW43. Primers P1 and P3
were used to amplify the 500-bp region upstream of YE3614, including the start
codon. This fragment was digested with NotI and XbaI and cloned into pKW44,
resulting in pSW42. Plasmid pSW45, for detection of secretion of YspM from
clinical isolate Y295, was constructed in a similar fashion using primers P1 and
P2. For detection of secretion of YE3614 via the Ysc T3SS, primers P124 and
P125 were used to amplify the yopE promoter region from JB580v, and the
resulting fragment was digested with NdeI. Next, the first 500 bp of YE3614 were
amplified with P126 and P2, and the product was digested with NdeI. Primers
P125 and P126 were engineered to include an NdeI site as well as a start codon.
The yopE promoter and YE3614 ORF digested fragments were ligated together
overnight at 16°C. This mixture was then used in a PCR with primers P124 and
P2, and the resulting product was digested with NotI and XbaI and cloned into
pKW44 digested with the same enzymes, generating plasmid pSW41.
The plasmid (pSW47) to construct the in-frame yscC null strain used in this
study was generated as follows. Primers P135 and P136 were used to amplify an
approximately 500-bp region upstream and including the start codon of yscC
from JB580v. Primers P137 and P138 were used to amplify an approximately
500-bp region downstream and including the stop codon of yscC. These two
fragments were digested with BamHI and ligated together. This product was then
used in a PCR with primers P135 and P138, and the resulting product was
digested with SalI and NotI and cloned into the same sites of pSR47S, resulting
in plasmid pSW47.
Plasmid pKW43 used to construct the in-frame ysaC null strain was gener-
ated in a similar manner using primers ysaC-delA and ysaC-delB to amplify the
fragment 500 bp upstream of ysaC, and primers ysaC-delC and ysaC-delD were
used to amplify the 500-bp region downstream. Plasmid pKW53 used to generate
the in-frame rcsB null strain was constructed in a similar fashion, with primers
rcsB-delA and rcsB-delB amplifying 500 bp upstream of the rcsB ORF and
primers rcsB-delC and rcsB-delD amplifying the 500 bp downstream.
The plasmids used to detect protein production in yeast were generated using
the Gateway system from Invitrogen. Briefly, primers P68 and P69 were used to
amplify the 900-bp coding region of YE3614 from JB580v. This product was
cloned into pENTR-SD-TOPO (Invitrogen) per the manufacturer’s protocol,
generating pSW11. Next, pSW11 and pDEST52 (Invitrogen) were combined
using the enzyme Gateway LR Clonase II (Invitrogen), according to the manu-
facturer’s instructions, resulting in pSW13, a C-terminal V5-tagged expression
vector for YspM from strain JB580v (YspMJB580v). pSW16 was generated in the
same fashion using primers P70 and P67 by first cloning the yspM ORF from
clinical isolate Y295 into pENTR-SD-TOPO (pSW12) and recombining pSW12
with pDEST52 to generate the C-terminal V5-tagged fusion protein. Briefly, the
H304N site-directed mutant in YspMY295 was generated as follows: primers P70
and P82, which contained the H304N mutation in P82, were used to amplify the
first 700 bp of yspMY295 from pSW12 that contained the histidine at position
304 replaced with an asparagine. Next, primers P81 and P67, which contained the
H304N mutation in P81, were used to generate a 200-bp product downstream
of and including the H304N mutation. These two products contained 35 bp of
overlap at their 3 or 5 ends, respectively, and were combined and used in a PCR
along with primers P70 and P67. The resulting product was cloned into pENTR-
SD-TOPO to generate pSW29. The C-terminal V5-tagged yeast expression
vector for YspM in the Y295 strain carrying the H304N mutation
[YspMY295(H304N)], pSW46, was generated using techniques described above.
TABLE 2. Primers
Name Sequence (5 to 3)
P1.......................................................................................................AAG GAA AAA AGC GGC CGC TAT ACT CAG TAT CAG GTG TTC
P2.......................................................................................................GCT CTA GAA CCA AGG GAT ACA ATA GCC AAA TC
P3.......................................................................................................GCC GCC CTA GTC TAG ACA TAA TTT CCT CTG GAT T
P27.....................................................................................................CCG CTC GAG ATG AGT ATT AAT TTT AAC CAC AAC
P67.....................................................................................................CAG TGT TGG TTT ACT GAA TTT TTC GG
P68.....................................................................................................CAC CAT GGG AAG TAT TAA TTT TAA CCA CAA C
P69.....................................................................................................GGA ACA TAT CCA GAT ATG ATA GGC GTG TTC
P70.....................................................................................................CAC CAT GGG AAT TAT TAA TTT AAA CCA CAA C
P81.....................................................................................................TCT TTT AAT GAC AAT TCA AAT CCA TCC CAA GAA TTG CAT GCC
P82.....................................................................................................GGC ATG CAA TTC TTG GGA TGG ATT TGA ATT GTC ATT AAA AGA
P124...................................................................................................ATA AGA ATG CGG CCG CGA ATT CCC CAA CTT TGA CAC
P125...................................................................................................GGG AAT TCC ATA TGT ATT TAT TCC CTT GGC
P126...................................................................................................GGA ATT CCA TAT GAG TAT TAA TTT TAA CCA CAA CAG
P128...................................................................................................GCT CTA GAC ATG ACT ATT TAT TCC CTT GGC
P135...................................................................................................ACG CGT CGA CAT GCA AAA TTT ACT AAA AAA CTT GGC
P136...................................................................................................CGC GGA TCC CGG AAA AGC CAT ATT ACT TTA ATT CC
P137...................................................................................................CGC GGA TCC AAG CGT GGC GTA TTG TGA
P138...................................................................................................ATA AGA ATG CGG CCG CGC TAA AGA AAC CTC AAT TCC
KW104 ..............................................................................................GCT CTA GAC AGC AAT CGC ATC AGG CTG GTT AC
KW105 ..............................................................................................CGG GAT CCT TAA TAG CCG GAA TCC TGG CGT TCC AC
KW154 ..............................................................................................GGT GAG GTC AGG AAA TCA ACC C
rcsB-delA..........................................................................................GCG TCG ACG ATG TGA TGG TGA CTG ATA ACC C
rcsB-delB ..........................................................................................CGG GAT CCT ACA TTA AGG TTG TTC ATG GTT ATG GG
rcsB-delC ..........................................................................................CGG GAT CCC AAG AGA AAG AAT AAC TTC TGT TC
rcsB-delD..........................................................................................ATA AGA ATG CGG CCG CTC AAT TGA CAG CTT TAG GTT ATC G
ysaC-delA .........................................................................................GCG TCG ACC CCT TGA TGC ACC AGA TGA TGC GAC
ysaC-delB..........................................................................................CGG GAT CCA GCG ACG GCA TCA AAC AGC TTG CC
ysaC-delC .........................................................................................CCG GGA TCC CGT CAG TTC TCT GAA ACT GAA CGC
ysaC-delD .........................................................................................ATA AGA ATG CGG CCG CCG CAA TGC TTC CAG TTG TTC GAG C
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In-frame deletion construction. The yscC in-frame deletion (YVM1374) was
constructed as follows. A total of 500 l of E. coli S17-1 pir carrying pSW47 was
mixed with 500 l of JB580v, plated onto LB agar, and incubated overnight at
26°C. The resulting lawn of cells was scraped and added to 1 ml of phosphate-
buffered saline and plated at various dilutions onto LB agar containing nalidixic
acid to select against E. coli and on kanamycin to select for plasmid integration.
The resulting colonies were plated onto LB agar containing nalidixic acid and 5%
sucrose to select for colonies that had undergone recombination and lost the
plasmid. The resulting colonies were checked for kanamycin sensitivity and
confirmed for the presence of the yscC deletion by PCR. Absence of Yop
secretion was confirmed using sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) analysis for separation of trichloroacetic acid-precip-
itated supernatants followed by Coomassie staining (S. E. Witowski and V. L.
Miller, unpublished results). The ysaC in-frame deletion (YVM1178) and the
rcsB (YVM1236) in-frame deletion were constructed in a similar fashion.
Protein secretion preparations, SDS-PAGE, and Western blot analysis. Se-
creted proteins were collected as described previously (47). Briefly, for detection
of secretion via the Ysa T3SS, saturated cultures grown overnight in LB without
NaCl at 26°C (noninducing conditions) were back-diluted to an optical density at
600 nm (OD600) of 0.2 into LB containing 290 mM NaCl (inducing conditions)
and grown for 6 h at 26°C. For detection of secretion via the Ysc T3SS, saturated
cultures grown overnight in LB medium at 26°C were back-diluted to an OD600
of 0.2 into LB containing 20 mM Na2C2O4 and 20 mM MgCl2 (inducing
conditions) and grown for 6 h at 37°C. Bacterial cells were removed from 5 ml of
culture by centrifugation for 1 min at 13,000 rpm; this process was repeated. The
supernatant was then passed through a 0.22-m-pore-size syringe filter. Cold
trichloroacetic acid was added to a final concentration of 10% (vol/vol) and
incubated at 4°C overnight. Samples were centrifuged for 10 min at 13,000 rpm
at 4°C. Supernatants were discarded, and the pellet was washed with cold acetone
and resuspended in 1 M Tris, pH 9.0. Samples were boiled for 5 min in 1
sample buffer; OD600 equivalents were loaded onto SDS-polyacrylamide gels
(31). Proteins were transferred to a nitrocellulose membrane for Western anal-
ysis. Blots were blocked for 1 h at room temperature in 1 Tris-buffered saline
and 0.1% Tween-20 (TBST) containing 5% milk. Primary antibody against CyaA
(purchased from List Biologicals and a gift from the laboratory of Erik Hewlett)
was added at a dilution of 1:5,000 and incubated at room temperature for 2 h.
Membranes were washed several times with 1 TBST and goat anti-mouse
immunoglobulin G-horseradish peroxidase (Sigma) secondary antibody diluted
1:15,000 in TBST containing 5% milk and incubated for 30 min at room tem-
perature. Membranes were washed again in TBST, and proteins were detected
by chemiluminescence (ECL; Amersham).
Translocation assays. The following protocol was adapted from Sory et al.
(37). Chinese hamster ovary (CHO) cells were passaged in F12 medium con-
taining 10% fetal bovine serum, and cells were grown at 37°C in the presence of
5% CO2 unless otherwise indicated. For translocation assays, CHO cells were
seeded into 24-well tissue culture plates at a density of 4  105 to 5  105
cells/well 24 h prior to the start of the translocation assay. Thirty minutes before
infection with Y. enterocolitica, cells were washed and covered with F12 medium
plus 5% fetal bovine serum containing 1 g/ml cytochalasin D. For analysis of
protein translocation via the Ysa T3SS, Y. enterocolitica was grown at 26°C
overnight in LB lacking NaCl and subcultured into LB containing 290 mM NaCl
at an OD600 of 0.2 and grown for 2 h at 26°C. Bacteria were added in triplicate
to CHO cells at a multiplicity of infection of 100:1 and incubated at 26°C in 5%
CO2 for 2 h. For analysis of protein translocation via the Ysc T3SS, Y. entero-
colitica was grown overnight in LB at 26°C, subcultured into LB to an OD600 of
0.2, and grown for 2 h at 37°C. Bacterial strains were added in triplicate to CHO
cells at a multiplicity of infection of 100:1 and incubated at 37°C in 5% CO2
for 2 h.
After infection, CHO cells were washed three times with phosphate-buffered
saline and lysed under denaturing conditions (50 mM HCl and boiling for 5 min).
The resulting lysate was neutralized with NaOH, and cyclic AMP (cAMP) was
extracted with ethanol. Lysate was then centrifuged at 13,000 rpm for 5 min, and
the supernatant was removed and dried in a Speed Vac; intracellular cAMP
levels were assayed by a commercially available enzyme immunoassay system
(Biotrak, Amersham).
RNA extraction and Northern blot analysis. Total cellular RNA was extracted
from cell pellets that had been stored at 80°C using Trizol-LS reagent (Invitro-
gen). Trizol was added to the frozen cell pellet to a density of 10 OD units/ml,
and RNA was extracted per the manufacturer’s instructions. Total RNA was
treated with DNase using DNA free, following the manufacturer’s protocol
(Ambion). For Northern blotting, 10 g of RNA was separated in a 1% form-
aldehyde agarose gel and transferred to nitrocellulose membranes by capillary
action (31). For dot blots, 5 g of RNA was mixed with 50 l of denaturing buffer
(50% formamide, 7% formaldehyde, 1 SSC [1 SSC is 0.15 M NaCl plus 0.015
M sodium citrate]) and transferred to nitrocellulose membranes by vacuum
suction (31). The yspM gene-specific probe was generated using primers P27 and
KW154 and labeled with [	-32P]dATP by random-primed labeling per the man-
ufacturer’s protocol (Roche). Next, the radiolabeled PCR probe was hybridized
to blots in 50% formamide buffer. To control for equivalent loading, the 16S
RNA was probed. An oligonucleotide probe (KW157) was labeled with
[
-32P]ATP by T4 polynucleotide kinase. Hybridization and washes were con-
ducted in a sodium pyrophosphate buffer (hybridization buffer containing 0.1%
sodium pyrophosphate, 4 SSC, 5 Denhardt’s reagent, 0.1% SDS, and 100
g/ml salmon sperm DNA; wash buffer containing 0.1% sodium pyrophosphate,
4 SSC, and 0.1% SDS) (S. Strand, personal communication). The yspM gene-
specific signal was normalized by dividing it by the 16S signal. Triplicate values
were averaged and normalized to the peak of expression (for time course anal-
ysis) or to the wild-type levels (for analysis of regulators). Specific mRNA signals
were quantified using an FLA-5000 phosphorimager and ImageGauge, version
4.22, software (Fuji Film Medical Systems, Stamford, CT).
Analysis of YspM toxicity in S. cerevisiae. Yeast cells containing pDEST52
(strain SCW06), pSW13 (SCW07), pSW16 (SCW08), or pSW46 (SCW11) were
grown overnight at 30°C in synthetic complete medium lacking uracil with 2%
glucose. Yeast was subcultured to an OD600 of 0.2 into synthetic complete
medium lacking uracil with 2% galactose and grown at 30°C. Samples were taken
every hour, and OD600 measurements were taken over the course of growth.
To examine expression of tagged protein, Western blot analysis to detect the
V5 epitope was performed. The following protocol was adapted from Sato et al.
(33). Briefly, at the end of the induction growth curve, OD equivalents of yeast
were collected by centrifugation, washed one time with water, immediately fro-
zen by a dry ice-ethanol bath, and stored at 80°C. Cell pellets were thawed and
resuspended in 100 l of breaking buffer (40 mM Tris, pH 7.0, 8 M urea, 5%
SDS, 0.1 M EDTA, 10% glycerol, 0.4 mg/ml bromophenol blue, 140 mM -mer-
captoethanol, and protease inhibitor cocktail [Roche Diagnostics]). The mixture
was boiled for 5 min and vortexed with an equal volume of glass beads for 1 min
before SDS-PAGE separation of proteins and Western blot analysis using pri-
mary mouse anti-V5 antibody (Sigma) diluted 1:2,000 in TBST and goat anti-
mouse immunoglobulin G-horseradish peroxidase (Sigma) secondary antibody
diluted 1:12,000 in TBST.
RESULTS
Identification of a potential Y. enterocolitica type III secreted
protein. Matsumoto and Young identified 15 proteins (Ysps)
that are secreted via the Ysa T3SS. Interestingly, most of these
proteins are encoded in locations distinct from the ysa locus in
the Y. enterocolitica JB580v genome (23). A genetic screen,
unrelated to type III secretion, conducted in our laboratory
brought to our attention a potential 16th Ysa type III secreted
protein, YE3614, encoded on the Y. enterocolitica JB580v chro-
mosome (P. Revell and V. L. Miller, unpublished results). The
results of this initial screen were complex, and thus YE3614
was not followed up on in that context. However, the similarity
of YE3614 to a type III secreted protein became of interest to
us and was studied further. The hypothesis that YE3614 could
be a type III secreted protein was based on protein sequence
analysis. One of the closest homologs of YE3614 is the SPI2
(Salmonella pathogenicity island 2) secreted effector, SseJ,
from Salmonella enterica. Additionally, like the Ysa T3SS,
YE3614 is present only in biotype 1B strains of Y. enterocolitica
(18). Furthermore, a YE3614 homolog is not found in Yersinia
pestis and Yersinia pseudotuberculosis, which also lack a Ysa
T3SS homolog. Based on this knowledge, we hypothesized that
YE3614 would most likely be a Ysa type III secreted protein
rather than a Ysc type III secreted protein. Examination of the
chromosomal region surrounding YE3614 reveals insight into
the evolution of this region of the chromosome (Fig. 1A).
Thomson et al. have identified a region that is hypervariable
among Y. enterocolitica biotypes, spanning from YE3450 to




arch 20, 2014 by W






YE3644, which they have termed the plasticity zone (38). The
authors speculate that the plasticity zone did not arise from a
single acquisition but, rather, from multiple independent in-
sertion events. Additionally, surrounding YE3614 is a region
containing remnants of an ancestral enteric flagellum cluster
termed flgII, (YE3610, YE3610A, YE3611, and YE3614A)
(38); many of these ORFs appear to be pseudogenes. Inter-
estingly, YE3614 does not have homology to a flagellar pro-
tein. However, downstream of YE3614 is a region termed
IS1330. This region is classified as a highly degenerative copy
of the Y. enterocolitica IS10-like transposase. Therefore, it is
possible that YE3614 was inserted into the genome in an event
distinct from the acquisition of the flgII. Two pieces of evi-
dence lead us to believe that YE3614 and YE3614A are not in
an operon. First, they are separated by 228 bp. Second, the GC
content of the genes within the flgII remnant, YE3610,
YE3610A, YE3611, and YE3614A, is 55%, 41%, 41%, and
38.7%, respectively, while the GC content for YE3614 is only
31%. This information, combined with the data collected by
Thomson et al., supports the hypothesis that YE3614 was ac-
quired more recently via a horizontal transfer event (38).
Both SseJ and YE3614 are classified as bacterial GDSL
lipases based on protein sequence. Members of this family
possess five blocks of amino acid identity, and lipase activity is
dependent on the presence of three blocks that contain resi-
dues comprising a catalytic triad (Ser, Asp, and His) of amino
acids (27, 40). In vitro studies reveal that SseJ plays a role in
Salmonella-containing vacuole maintenance within infected
host cells (5, 13, 30). In vivo analyses have shown that SseJ is
required for full virulence in a competitive index model of
infection in the mouse model (27). Additionally, mutations in
the predicted catalytic residues of the protein SseJ ablate dem-
onstrated in vitro lipase activity, as well as render the mutant
strains unable to compete to wild-type levels in the competitive
index mouse model of infection (27). Analysis of the protein
sequence of YE3614 revealed that two of the three (Ser, His,
and Asp) catalytic residues are present; however, the histidine-
containing block of amino acid identity is absent from the
protein sequence (Fig. 1B). A histidine present at the end of
the protein potentially could function as the required catalytic
residue; however, this histidine is not encoded in the block of
conserved amino acids where this residue is typically found.
YE3614 is secreted by the Ysa T3SS. The homology of
YE3614 to a SPI2-secreted effector suggested that YE3614
might be secreted by Y. enterocolitica. While we hypothesized
that YE3614 was a Ysa type III secreted protein, it was nec-
essary to determine if YE3614 was indeed secreted and, if so,
if it was dependent on the Ysa or the Ysc T3SS. To test this, a
CyaA reporter fusion was constructed containing the predicted
promoter and the first 150 amino acids of YE3614 from Y.
enterocolitica strain JB580v fused to the B. pertussis adenylate
cyclase gene, cyaA (pSW43). To examine secretion by the Ysa
T3SS, pSW43 was transformed into JB580v (wild type), and
bacteria were grown under Ysa-inducing conditions at 26°C in
the presence of 290 mM NaCl. Bacterial cells and culture
supernatants were harvested after 6 h and analyzed by Western
blotting using an antibody against CyaA. Under these condi-
tions, a CyaA signal was present in culture supernatants (Fig.
2A). Thus, YE3614 was renamed YspM in keeping with the
nomenclature established for the Ysa T3SS. To determine
which T3SS was responsible for this event, pSW43 was trans-
formed into JB580v lacking a functional Ysc T3SS (yscC;
strain YVM1374) and a strain lacking a functional Ysa T3SS
(ysaC; YVM1178). YscC encodes the secretin for the Ysc
T3SS, and YsaC is predicted to be the secretin for the Ysa
T3SS based on homology to other T3SS secretins (12, 20).
Cultures were again grown under Ysa-inducing conditions, and
FIG. 1. Genomic location of YE3614 and sequence alignment of
the GDSL lipase, SseJ, from S. enterica, and YE3614 from Y. entero-
colitica JB580v. (A) Chromosomal location of YE3614 and its sur-
rounding ORF. YE3610, homology to a lipoprotein; YE3610A, ho-
mology to a flagellar protein, pseudogene; YE3611, homology to a
regulator, pseudogene; YE3614, homology to a type III secreted pro-
tein; YE3614A, homology to a flagella regulator, pseudogene; IS1330,
disrupted ORF with homology to the IS10-like transposase from Y.
enterocolitica. Gray arrows indicate ORFs with homology to ancestral
flagellum cluster. (B) An amino acid alignment of YE3614 with SseJ
from S. enterica. The five blocks of amino acid identity found in GDSL
lipases are underlined. Arrowheads indicate catalytic residues (Ser,
Asp, and His), black boxes indicate identical amino acids, and gray
boxes indicate similar amino acids.
FIG. 2. YE3614 is secreted into culture supernatants. (A) pSW43
(JB580v yspM ORF and promoter) was transformed into the wild-type
(WT; JB580v), ysaC (YVM1178), and yscC (YVM1374) strains.
Bacteria were grown under Ysa T3SS-inducing conditions. Samples
were harvested after 6 h, and samples were prepared for Western
analysis with anti-CyaA antibody as described in Materials and Meth-
ods. (B) pSW41 (JB580v yspM ORF and yopE promoter) was trans-
formed into the strains listed above. Bacteria were then grown under
Ysc T3SS-inducing conditions (37°C and absence of Ca2), and sam-
ples were prepared as described in panel A. (C) pSW45 (Y295 yspM
ORF and promoter) was transformed into the strains listed above and
grown under Ysa T3SS-inducing conditions, and supernatants and cells
were analyzed as described in panel A.
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bacterial cells and supernatants were harvested. Protein secre-
tion was seen in bacteria lacking a Ysc T3SS but not in a strain
lacking a Ysa T3SS (Fig. 2A).
To determine if YspM was also secreted by the Ysc T3SS,
wild-type, yscC, and ysaC strains of bacteria carrying pSW43
were grown under Ysc-inducing conditions, at 37°C in the
absence of Ca2, and bacterial cells and culture supernatants
were examined for the presence of CyaA signal by Western
blotting. Under these conditions, no CyaA signal was present
in either cells or supernatants in any strain examined (data not
shown). Together, these data support the model that YspM is
a type III secreted protein and is natively secreted by the Ysa
T3SS but not the Ysc T3SS. However, the lack of secretion of
YspM by the Ysc T3SS may be due to lack of expression under
Ysc-inducing conditions.
To test the possibility that the lack of YspM secretion by the
Ysc T3SS is due to a lack of protein production and not the
specificity of the apparatus itself, expression of the YspM-
CyaA fusion protein was placed under the control of the yopE
promoter (pSW41), a promoter that is active under Ysc induc-
ing conditions. This promoter was chosen as it is a promoter
native to Y. enterocolitica that is strongly expressed under Ysc
T3SS-inducing conditions. When pSW41 was transformed into
JB580v and bacteria were grown under Ysc-inducing condi-
tions, CyaA signal was detected in the culture supernatants
(Fig. 2B). To determine if this secretion was via the Ysa or the
Ysc T3SS, pSW41 was transformed into the ysaC and the
yscC strains. CyaA signal was detected in culture superna-
tants of the ysaC strain but not in the yscC strain (Fig. 3B).
This demonstrates that the YspM protein is capable of being
secreted by Ysc T3SS as well as the Ysa T3SS, and the pres-
ence or absence of protein secretion is dependent on protein
production rather than specificity of the apparatus.
YspM is translocated into host cells via the Ysa T3SS. To
determine if YspM could be translocated into mammalian
cells, the CyaA reporter fusion used to detect secretion, plas-
mid pSW43, was also used to examine translocation. Upon
translocation of CyaA into the host cell cytosol, calmodulin
present there can bind CyaA and activate its ability to catalyze
the conversion of ATP to cAMP, which can subsequently be
measured by enzyme-linked immunosorbent assay (37). Thus,
an increase in cAMP levels corresponds with a protein that is
translocated by the bacterium into the host cell. CHO cells
were infected for 2 h at 26°C with the wild type, a strain lacking
the pYVe8081 virulence plasmid that contains the entire ysc
locus and thus is deficient for secretion via the Ysc T3SS
(JB580c), and ysaC, all containing pSW43. Under these con-
ditions there was a significant increase in intracellular cAMP
levels in both wild-type and JB580c strains but not in the ysaC
mutant (Fig. 3). No increase in cAMP levels was detected in
the negative control strain carrying a plasmid with the pre-
dicted yspM promoter alone driving cyaA expression, pSW42.
This indicates that YspM is translocated into CHO cells under
these conditions, and this event requires a functional Ysa
T3SS. When these assays were repeated under Ysc T3SS-in-
ducing conditions, no rise in cAMP levels was detected (data
not shown).
Expression of yspM is regulated similarly to the ysa operon.
As yspM is encoded outside of the ysa locus, we sought to deter-
mine if the factors that control transcription of the ysa locus also
affect expression of yspM. Northern blot analysis demonstrated
that yspM was maximally expressed 2 h into the growth curve
when bacteria were grown at 26°C in the presence of 290 mM
NaCl. There was a 3.3-fold induction of yspM expression in the
presence of NaCl as opposed to the absence of NaCl (Fig. 4A).
Next, we looked for the presence of yspM transcript in mutants
of known ysa regulators: ysaE (strain YVM932), sycB
(YVM981), ysrS (YVM969), ysrR (YVM1006), and rcsB
(YVM1236). For these experiments wild-type and mutant
FIG. 3. YspM is translocated into CHO cells by the Ysa T3SS.
pSW43 (JB580v yspM ORF and promoter) was transformed into the
wild-type (WT; JB580v), pYVe8081v-cured (JB580c), and yscC
(YVM1374) strains. Strains were used to infect CHO cells in triplicate
at 26°C for 2 h. Cytosolic levels of cAMP were measured as described
in Materials and Methods and compared to uninfected CHO cells and
CHO cells infected with JB580v carrying the negative control plasmid,
pSW42 (JB580v yspM promoter). Results of a representative assay are
shown.
FIG. 4. yspM is regulated in a manner similar to the ysa operon.
(A) Triplicate saturated cultures of wild-type bacteria were grown in
LB and subcultured into LB containing either 290 mM or 0 mM NaCl
and grown at 26°C for the indicated times. RNA was extracted and
used for Northern blot analysis. Data are represented as a relative
percentage of the maximal expression. (B) Triplicate cultures of wild-
type (WT), ysaE, sycB, ysrS, ysrR, and rcsB strains were grown
as described in panel A, and RNA was extracted 2 h into the growth
curve. Expression in the wild type is set to 100%, and expression of
yspM in the various mutants is represented as a relative percentage of
the expression seen in the wild type.
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strains of bacteria were grown at 26°C in the presence of 290
mM NaCl, and RNA was extracted at 2 h as this is when
maximal yspM transcript is present in wild-type cells. Expres-
sion of yspM was 16% of the wild-type level in ysaE, 18% in
sycB, 27% in ysrS, 60% in ysrR, and 33% in rcsB (Fig.
4B). Together, these data indicate that yspM expression is
controlled by the same factors as the ysa apparatus; however,
the mechanism of this regulation remains to be determined.
YspM from Y. enterocolitica JB580v lacks a catalytic domain
required for yeast growth inhibition. As many type III secreted
proteins have been shown to exert an effect on eukaryotic cells,
we sought to determine if YspM also had any effect. The use of
an S. cerevisiae system as a tool to assess protein functionality
has been described for other type III secreted effectors (21, 33,
35, 36). To determine if YspM was toxic for eukaryotic cell
growth, a YspM fusion protein under the control of the GAL1
promoter was constructed with a V5 tag at the C terminus
(plasmid pSW13). This plasmid was then used to examine the
effects of YspM on the yeast S. cerevisiae. The GAL1 promoter
is repressed when yeast cultures are grown in glucose and
activated when grown in galactose, thus allowing for control of
expression of potentially toxic proteins. When grown under
noninducing conditions (2% glucose), yeast containing pSW13
(strain SCW07) had growth rates similar to the vector-only
control, which does not encode a tagged protein (SCW06)
(data not shown). When yeast was grown under inducing con-
ditions (2% galactose), growth rates of strains SCW06 and
SCW07 were similar (data not shown). Protein production was
confirmed for SCW07 using Western blot analysis against the
V5 tag (data not shown). Knowing that YspM from Y. entero-
colitica JB580v lacked the conserved histidine domain common
to GDSL lipases, these data raised the possibility that absence
of toxicity toward eukaryotic cells may be due to the lack of the
conserved His catalytic residue.
After this result was observed, the sequence of yspM from Y.
enterocolitica JB580v was analyzed further, and it was discov-
ered that the catalytic His residue-containing domain is
present in a different reading frame but not translated due to
a frameshift mutation (Fig. 5). As it was discovered that yspM
is present in other biotype 1B strains, we sequenced the cor-
responding gene from eight additional biotype 1B clinical iso-
lates to determine the prevalence of this frameshift mutation.
Seven of these strains had sequences of yspM that encoded
proteins containing all three catalytic residue-containing do-
mains found in GDSL lipases; however, one strain, 634-83, was
truncated within the first half of the protein (Fig. 5A). Strain
Y295 was chosen for further analysis as this is also an O:8
serotype strain, as is JB580v. Comparison of yspM from JB580v
(yspMJB580v) and yspM from Y295 (yspMY295) revealed the
location of the frameshift mutation responsible for the trun-
cation of yspMJB580v (Fig. 5B). To determine if YspMY295 was
also secreted by the Ysa T3SS, a CyaA reporter fusion was
constructed containing 500 bp of the promoter region and the
first 150 amino acids of YspMY295 (pSW45). This construct was
transformed into a wild-type, yscC, and ysaC strains. CyaA
signal was detectable by Western blot analysis in the wild type
and yscC only when cultures were grown under Ysa-inducing
conditions, demonstrating that the yspM promoter from strain
Y295 is active in our laboratory strain (JB580v) and that this
protein can be secreted by the Ysa T3SS (Fig. 2C).
YspMY295 is toxic for yeast growth, and this toxicity is de-
pendent on the predicted catalytic His. Based on the discovery
of YspM containing the predicted catalytic His residue,
YspMY295, we sought to determine if the presence of this domain
conferred toxicity for yeast growth. As with YspMJB580v, a
YspMY295-V5 fusion protein was constructed under the control
of the GAL1 promoter (pSW16). When yeast carrying pSW16
(SCW08) was grown in 2% glucose (repressing conditions), there
was no effect on growth compared to control strain SCW06 or to
SCW07 (Fig. 6A). However, when SCW08 was grown in 2%
galactose (inducing conditions), yeast growth was completely in-
hibited compared to strains carrying either vector alone (SCW06)
or YspMJB580v-V5 (SCW07) (Fig. 6B). These data suggest that
YspM possesses toxic activity toward eukaryotic cells and that this
activity requires the presence of the histidine-containing domain
found in GDSL lipases. To determine if, indeed, the predicted
catalytic His was responsible for the toxicity seen in S. cerevisiae,
a site-directed mutant was constructed changing the histidine at
position 304 to an aspargine, YspMY295(H304N). A V5 fusion pro-
tein was constructed with this mutant, YspMY295(H304N)-V5
(pSW46) and transformed into S. cerevisiae (SCW11). Analysis of
yeast growth under inducing conditions revealed that mutation of
this His ablates the toxic effects of YspMY295 expression as
growth rates were similar to both vector control (SCW06) and
YspMJB580v-V5 (SCW07) (Fig. 6B). Protein production was con-
firmed for SCW07 and SCW11 using Western blot analysis
against the V5 tag, but there was no signal detected for SCW08
(Fig. 6C). One possible explanation for the lack of signal for strain
SCW08 is that due to the toxic nature of expression of YspMY295,
yeast cells are never able to enter a growth phase where detect-
able amounts of YspMY295 are produced. Another possibility is
that surviving yeast cells have developed mutations within plasmid
pSW46 such that YspMY295 is no longer produced. Together,
these data demonstrate that YspM toxicity is likely due to pos-
session of the catalytic triad of amino acids common to GDSL
lipases.
DISCUSSION
The Ysa T3SS was previously shown to secrete 15 different
proteins into culture supernatants (23). Here, we identify a
new protein from Y. enterocolitica that is natively secreted by
the Ysa T3SS, named YspM. The yspM ORF is expressed
under the same conditions as the ysa locus and requires for full
expression the known ysa regulators, YsaE, SycB, YsrRS, and
RcsB. In addition to being secreted by the Ysa T3SS,
YspMJB580v is translocated into host cells by the Ysa T3SS
when cultures are grown under Ysa-inducing conditions. When
YspM is expressed from a promoter active under Ysc secretion
conditions, YspM can be secreted by the bacterium via the Ysc
T3SS. Other studies in Y. enterocolitica have shown that YopE,
YopN, and YopP are secreted by the Ysa and the Ysc T3SS,
and YplA, natively a flagellar type III secreted protein, can be
secreted by both the Ysc and Ysa T3SS (45–47). As it is still
unclear what signals within the host activate the various T3SSs,
these data suggest that during infection (at least for a subset of
type III secreted proteins), if YspM is expressed, then it po-
tentially could be secreted by any T3SS. This theory is further
supported by work showing that deletion of some individual ysp
genes had a greater impact on virulence than deletion of the
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entire Ysa apparatus (23). One possible explanation for this
apparently anomalous observation is that when the Ysa T3SS
is not present, these Ysps are being secreted by alternative
means during infection of the host, such as the Ysc T3SS.
Based on sequence homology, YspM is characterized as a
bacterial lipase. These proteins have the ability to cleave fatty
acid chains from the glycerol backbone and may also have
cholesterol acyltransferase activity (40). Much work has been
done to characterize a close homolog, SseJ, an SPI2 secreted
effector from S. enterica, and to demonstrate its role in Salmo-
nella-containing vacuole maintenance within infected cells and






























































































































































FIG. 5. Sequence alignment of YspM from nine biotype 1B isolates of Y. enterocolitica. (A) Amino acid alignment of YspM from these strains
demonstrates the presence of the fifth conserved domain found in GDSL lipases (underlined) in all but two isolates, JB580v and 634-83, and the
location of the predicted catalytic histidine (arrowhead). The alignment also reveals the presence of various amino acid changes among the
different YspM isolates examined. Unique amino acids are in black boxes, and similar amino acids are in gray boxes. (B) The DNA sequences of
YspMJB580v and YspMY295 reveal the insertion of an adenosine (bold) which shifts the reading frame to encode a stop codon (italicized). The
reading frame of each sequence is noted.
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for this activity. The SPI2 T3SS is crucial to the ability of
Salmonella to replicate within host cells and to achieve full
virulence within the mouse (reviewed in references 11, 14, and
9). The similarity between SseJ and YspM would lead one to
think that YspM might also play a role in the survivability of Y.
enterocolitica within infected host cells. While Y. enterocolitica
is typically thought of as an extracellular pathogen, there is
some evidence to support the idea that the bacterium can
replicate intracellularly. Two studies have shown an outgrowth
of Y. enterocolitica within infected host cells. In unactivated
J774.1 macrophages, there was a 30-fold increase in the num-
ber of bacteria obtained 25 h postinfection (29). Also, another
study reported a 110-fold increase in bacteria recovered from
infected J774 macrophages at 24 h postinfection (7). While the
role of intracellular survival remains poorly understood in the
context of Y. enterocolitica pathogenesis, it is possible that
YspM, similar to SseJ, may play a role in that process.
While there is little sequence similarity, another possibility is
that YspM acts like the phospholipase ExoU, a type III se-
creted protein from Pseudomonas aeruginosa. ExoU is an im-
portant virulence factor in the mouse model of infection and a
potent cytotoxin causing multiple effects on a variety of cell
types, including yeast, and these toxic effects are due, in part,
to the phospholipase activity of ExoU (1, 33; also reviewed in
reference 34). Like Y. enterocolitica, P. aeruginosa is an extra-
cellular pathogen that exerts its effects on eukaryotic cells, in
part, through a T3SS. It has been shown that ExoU requires
the eukaryotic Cu2/Zn2 superoxide dismutase (SOD1) as a
cofactor (32). Efforts to date in our laboratory have failed to
demonstrate lipase activity for purified recombinant YspM
(S. E. Witowski and V. L. Miller, unpublished results). Perhaps
this is due to the requirement of a specific eukaryotic cofactor,
similar to ExoU. Continued analysis of the enzymatic proper-
ties of YspM may help to determine if this protein functions to
aid in either intracellular survival, like SseJ, or extracellular
survival, like ExoU.
Analysis of yspM in strain JB580v of Y. enterocolitica reveals
the presence of a naturally occurring mutation. This mutation
truncates the protein such that the catalytic His-containing
domain is no longer encoded by yspM. It was determined that
this mutation was not acquired by passage of JB580v through
our laboratory as a strain of JB580v from the laboratory of B.
Wren also contained the same point mutation (Witowski and
Miller, unpublished). When yspM from eight other clinical
isolates was sequenced, seven of these strains did not have the
mutation, and the yspM sequence did encode the His-contain-
ing domain. The eighth strain sequenced (634-83) contained a
point mutation that truncated the protein within the first half
of the protein. The strains sequenced were all biotype 1B
strains and comprised several different serotypes. When a rep-
resentative isolate, YspMY295, was assayed in yeast cells, its
expression was toxic for yeast growth. Mutational analysis re-
vealed the predicted catalytic His to be required for this tox-
icity, suggesting that YspM has potent biological activity and
that this activity is dependent on the His-containing domain
found in all GDSL bacterial lipases. Further investigation of
the mechanism of YspM lethality in yeast may help elucidate a
role for this protein in Y. enterocolitica pathogenesis.
Howard et al. in their comparative phylogenomic study of
the evolution of Y. enterocolitica also found that yspM was
present only in the eight highly pathogenic strains they exam-
ined (18). The information gathered in their work provides
excellent insight into the evolution of the pathogenicity of Y.
enterocolitica. Their discovery that only 20.8% of the total
genome of all strains examined (including strains of high and
low degrees of pathogenicity and nonpathogenic strains) was
conserved as core genes indicates that the majority of the
genome is distinct between the various strains (18). These data,
combined with the location of a transposase-like element up-
stream of yspM, indicates that the gene was possibly acquired
via horizontal transfer. The discovery of the inactive form of
yspM in a strain of Y. enterocolitica (JB580v) that is still highly
pathogenic to both people and mice is intriguing. These ob-
servations raise questions about when these mutations arose as
FIG. 6. YspMY295 is toxic for yeast growth. Yeast carrying plasmids
pDEST-52 (strain SCW06), pSW13 (YspMJB580v-V5, strain SCW07),
pSW16 (YspMY295-V5, strain SCW08), and pSW46 (YspMY295H304N-V5,
strain SCW11) were analyzed for growth under induction conditions
(A) and noninduction conditions (B). Samples were taken over the
course of the growth curve and OD600 readings were measured. Rep-
resentative assays are shown. (C) Western blot analysis on cellular
lysates of SCW07, SCW08, and SCW11 using anti-V5 antibody. Sam-
ples were prepared as described in Materials and Methods.
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well as about the interplay of YspM with other Ysa type III
secreted effectors and their role in pathogenesis.
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